Endocrine Abstracts

We present a 37-year-old gentleman (Mr. A) who self-referred to the endocrine clinic for review of his testosterone replacement therapy.He required testosterone replacement therapy aged 11 years old following surgical removal of underdeveloped testes of unknown aetiology. He was prescribed testosterone injections until the age of 22 years old when testosterone patches were trialled, which he did not tolerate. He commenced testosterone replacement gel (TE...

Primary hypoparathyroidism is a rare condition. Contrary to other endocrine deficiencies treated with hormone replacement, recombinant parathyroid hormone (PTH) is not currently licensed for its treatment in Europe. Emerging evidence of efficacy and safety of recombinant PTH in treating resistant hypoparathyroidism will hopefully provide a new tool in managing this challenging condition.This is the case of a 45 year-old woman presenting with gradually wo...